Skip to main content

Technologies

27 results found
Microfluidics Pharmaceuticals / Nutraceuticals
Technologies
ID: 2021-010 Using the power of Junctional Adhesion Molecules combined with the target of CAR-T to inhibit cancer metastasis and eradicate tumors.
Technologies
ID: 2019-051 Researchers at BYU have discovered antioxidants that are significantly more effective than current available antioxidants.
Technologies
ID: 2019-015 Recombinant human Gal-1 treatment improves membrane repair capacity, increases myogenic markers and decreases inflammation in dysferlin deficient myotubes, providing novel evidence regarding how Gal-1 favorably improves muscle function in LGMD2B.
Technologies
ID: 2018-057 and 2014-098 BYU has discovered monocytes in the blood that provide a direct correlation to dopamine levels in the brain.
Technologies
ID: 2018-037 This technology is based on the use of phages infecting a bacteria and, as a byproduct of phage infection, antimicrobial components are released that can kill nearby infectious pathogens
Technologies
ID: 2018-035 The Paper Lateral Flow Immunoassay (pLFI) technique improves upon the traditional LFI, commonly recognized as diagnostic blood tests or pregnancy tests, reducing the costs of materials and precision in manufacturing.
Technologies
ID: 2018-014 A single-step process for creating porous polymer monoliths for DNA extraction
Technologies
ID: 2018-006 Optical Trap 3D Printing can be used to selectively print items, in-situ, on existing surfaces in any orientation and can do so without the need to immerse that surface in liquid.
Technologies
ID: 2017-050 A method of producing microfluidic channels by means of an innovative 3D printing process and a novel channel narrowing technique.